Palantir's NHS Data Platform Sparks Fears of Government Power Abuse
The UK government is actively encouraging health bodies across the nation to adopt the Federated Data Platform, a system delivered by the controversial data analytics firm Palantir. This push comes despite mounting concerns from health leaders and advocacy groups about the potential for government overreach and privacy violations.
Contract Details and Government Support
In 2023, Palantir Technologies secured a substantial £330 million contract with NHS England to implement the Federated Data Platform. Health Secretary Wes Streeting has publicly endorsed the platform, stating it will modernise the NHS and bring it into the digital age. The government views FDP as a critical tool for improving healthcare efficiency and patient outcomes.
Medact Report Highlights Risks
A detailed briefing from the health justice charity Medact, released recently and supported by doctors, lawyers, patients, and human rights organisations, raises alarm bells. The report, shared with hospital trusts and integrated care boards nationwide, warns that Palantir's software could facilitate data-driven abuses of power. Medact specifically points to the risk of enabling US-style immigration raids, similar to those conducted by ICE, which uses Palantir technology for cross-governmental data analysis.
Reform UK's Plans and Legal Implications
The concerns are amplified by political developments. Reform UK, led by Nigel Farage, has announced intentions to create a UK version of ICE, promising to use data-sharing powers for mass deportations. A 2025 policy document from Reform outlines plans for automatic data exchange between the Home Office, NHS, and other agencies. While Palantir asserts that using data in such ways would be illegal under current contracts, critics fear that future legislative changes could legitimise these practices.
Public and Institutional Resistance
Resistance to the FDP is growing. Greater Manchester Integrated Care Board, responsible for 2.8 million people, has deferred adoption, citing concerns over value for money and public trust risks. Additionally, over 50,000 patients have written to local trust boards urging rejection of the platform. Dr Rhiannon Osborne from Medact emphasises that Palantir's involvement represents an expansion of invasive surveillance practices in the UK.
Palantir's Defence and Broader Use
Palantir has defended its role, highlighting positive impacts such as helping deliver 100,000 additional operations and reducing discharge delays. A company spokesperson stated that data usage is strictly controlled by the NHS and complies with legal requirements. Palantir's software is already utilised by UK police forces and the Ministry of Defence, with the company engaging in policy consultations with the government.
Call to Action and Future Implications
The Medact report urges NHS trusts and integrated care boards to decline the FDP and calls for NHS England to terminate the contract. It argues that partnering with Palantir could erode patient trust and displace local data solutions. As debates continue, the integration of Palantir into the NHS remains a contentious issue, balancing technological advancement against fundamental privacy and ethical considerations.
